108 studies found for:    Open Studies | "Diabetic Retinopathy"
Show Display Options
Rank Status Study
21 Recruiting Intravitreal Ozurdex After Pars Plana Vitrectomy for Proliferative Diabetic Retinopathy
Condition: Proliferative Diabetic Retinopathy
Interventions: Drug: Intravitreal dexamethasone implant;   Procedure: Vitrectomy
22 Not yet recruiting Study to Evaluate Effects of Emixustat Hydrochloride in Subjects With Proliferative Diabetic Retinopathy
Condition: Proliferative Diabetic Retinopathy
Interventions: Drug: emixustat hydrochloride;   Other: Placebo
23 Recruiting Phase III Study of Compound Danshen Dripping Pills to Treat Diabetic Retinopathy
Condition: Non-proliferative Diabetic Retinopathy
Interventions: Drug: Compound danshen dripping pills;   Drug: Placebo
24 Not yet recruiting Study of the Efficacy and Safety of Intravitreal (IVT) Aflibercept for the Improvement of Moderately Severe to Severe Nonproliferative Diabetic Retinopathy (NPDR)
Condition: Nonproliferative Diabetic Retinopathy
Interventions: Drug: Intravitreal aflibercept injection [IAI];   Drug: Sham
25 Recruiting Multicenter 12 Months Clinical Study to Evaluate Efficacy and Safety of Ranibizumab Alone or in Combination With Laser Photocoagulation vs. Laser Photocoagulation Alone in Proliferative Diabetic Retinopathy (PRIDE)
Condition: Proliferative Diabetic Retinopathy (PDR)
Interventions: Drug: Ranibizumab;   Procedure: Laser photocoagulation;   Procedure: Ranibizumab & laser photocoagulation
26 Recruiting A Clinical Trial Designed to Evaluate the Safety and Efficacy Study of Luminate® in Inducing PVD (Posterior Vitreous Detachment) in Non-Proliferative Diabetic Retinopathy
Condition: Non-Proliferative Diabetic Retinopathy
Interventions: Drug: 1.0mg Luminate®;   Drug: 2.0mg Luminate®;   Drug: 3.0mg Luminate®;   Other: Balanced Salt Solution for intravitreal injection in 0.10cc
27 Recruiting Comparison of Interval Variation and Dosage in Preoperative Bevacizumab Administration in Proliferative Diabetic Retinopathy Patients Undergoing Vitrectomy
Condition: Proliferative Diabetic Retinopathy, Pars Plana Vitrectomy, Intravitreal Bevacizumab
Intervention: Drug: Intravitreal bevacizumab
28 Recruiting The Effect of Hyperbaric Chamber Treatment on Patients With Diabetic Retinopathy
Condition: Does Hyperbaric Chaber Treatment Improve Diabetic Retinopathy
Intervention:
29 Unknown  Effect of Folic Acid, Vitamin B6 and Vitamin B12 in Diabetic Retinopathy
Conditions: Non Proliferative Diabetic Retinopathy;   Proliferative Diabetic Retinopathy
Interventions: Drug: Folic Acid, vit B6 and B12;   Drug: Placebo
30 Unknown  Intravitreal Adalimumab in Refractory Diabetic Retinopathy, Choroidal Neovascularization or Uveitis: A Pilot Study
Conditions: Uveitis;   Diabetic Retinopathy;   Choroidal Neovascularization
Intervention: Drug: adalimumab
31 Unknown  A Safety and Efficacy Study of Vitreosolve® for Non-Proliferative Diabetic Retinopathy Subjects
Condition: Diabetic Retinopathy
Intervention: Drug: Vitreosolve
32 Unknown  Intravitreal Bevacizumab for Management of Active Progressive Proliferative Diabetic Retinopathy (PDR)
Condition: Diabetic Retinopathy
Intervention: Drug: bevacizumab
33 Unknown  The Effect of Intravitral Injection of Triamcinolone Combined With Cataract Surgery (Phacoemulsification) on Diabetic Macular Edema and Diabetic Retinopathy
Condition: Diabetic Retinopathy
Intervention: Drug: Triamcinolone
34 Unknown  Use of Intravitreal Ranibizumab in the Treatment of Vitreous Hemorrhage
Conditions: Diabetic Retinopathy;   Vitreous Hemorrhage
Intervention: Drug: intravitreal ranibizumab injections
35 Recruiting Anti-VEGF Treatment for Prevention of PDR/DME
Conditions: Diabetic Retinopathy;   Diabetic Macular Edema
Interventions: Procedure: Prompt Sham;   Drug: Prompt aflibercept;   Procedure: Deferred laser;   Drug: Deferred aflibercept
36 Unknown  Safety and Efficacy of Low-Fluence PRP for PDR
Condition: Proliferative Diabetic Retinopathy
Interventions: Device: Low-fluence PRP with 532nm green LASER;   Device: Full-Fluence PRP with 532nm LASER
37 Recruiting Safety and Effectiveness Study of 532nm Laser Subthreshold Panretinal Photocoagulation for Severe NPDR
Condition: Severe Non-proliferative Diabetic Retinopathy
Interventions: Radiation: T-PRP;   Radiation: S-PRP
38 Unknown  Changes in Electroretinogram and Contrast Sensitivity After PASCAL Treatment
Conditions: Non Proliferative Diabetic Retinopathy;   Proliferative Diabetic Retinopathy
Intervention: Procedure: PASCAL laser treatment
39 Unknown  Changes in Macular Thickness After Patterns Scan Laser
Conditions: Non Proliferative Diabetic Retinopathy.;   Proliferative Diabetic Retinopathy.
Intervention: Device: Panretinal photocoagulation with PASCAL system
40 Unknown  Perfluorocarbon Perfused Vitrectomy and 3D Vitrectomy System in Advanced Diabetic Retinopathy
Condition: Diabetic Retinopathy
Intervention: Procedure: Vitrectomy

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years